(Q45363831)

13 December 2017

title

Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma (English)

1 reference

13 December 2017

1 reference

1 reference

Liang Huang

1

1 reference

13 December 2017

Jing Li

2

1 reference

13 December 2017

Wan Yee Lau

3

1 reference

13 December 2017

Jianjun Yan

4

1 reference

13 December 2017

Feiguo Zhou

5

1 reference

13 December 2017

Caifeng Liu

6

1 reference

13 December 2017

Xianghua Zhang

7

1 reference

13 December 2017

Jun Shen

8

1 reference

13 December 2017

Mengchao Wu

9

1 reference

13 December 2017

Yiqun Yan

10

1 reference

13 December 2017

publication date

1 January 2012

1 reference

Journal of Gastroenterology and Hepatology

13 December 2017

published in

1 reference

13 December 2017

volume

27

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

158-164

1 reference

13 December 2017

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Candidates for therapy: HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06888.X

10.1111/J.1440-1746.2011.06888.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference